13659-98-8

Basic information

• Product Name: METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE)
• Synonyms: METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE);4-AMino-6-chloro-N3-Methyl-1,3-benzenedisulfonaMide;6-amino-4-chloro-N1-methyl-1,3-benzenedisulfonamide;4-amino-6-chloro-3-N-methylbenzene-1,3-disulfonamide
• CAS NO: 13659-98-8
• Molecular Formula: C₇H₁₀ClN₃O₄S₂
• Molecular Weight: 299.755
• Product Categories: Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds
• Mol File: 13659-98-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE)(CAS DataBase Reference)
• NIST Chemistry Reference: METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE)(13659-98-8)
• EPA Substance Registry System: METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE)(13659-98-8)

Safety Data

• Hazardous Substances Data: 13659-98-8(Hazardous Substances Data)

Usage

Description

METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE) is a chemical compound derived from the Polythiazide class, which is known for its diuretic properties. This specific compound is a metabolite found in dogs and has potential applications in the development of diuretic agents due to its structural similarities with known diuretics.

Uses

Used in Pharmaceutical Industry:
METHYCLOTHIAZIDE RELATED COMPOUND A (100 MG) (4-AMINO-6-CHLORO-N-3-METHYL-M-BEN-ZENEDISULFONAMIDE) is used as a reactant for the preparation of potential diuretic agents. Its chemical structure and properties make it a valuable component in the synthesis of new diuretic drugs, which can be used to treat various medical conditions related to fluid retention and high blood pressure.
Additionally, as a metabolite found in dogs, this compound may also be utilized in veterinary medicine for the development of diuretic medications specifically tailored for canine patients, taking into account their unique metabolic processes and physiological differences compared to humans.

Upstream product

• 91818-08-5 6-chloro-2-methyl-7-methylsulfamoyl-1,1-dioxo-1,2,3,4-tetrahydro-1λ⁶-benzo[1,2,4]thiadiazine-3-carboxylic acid 
• 89813-57-0 6-chloro-2-methyl-1,1,3-trioxo-1,2,3,4-tetrahydro-1λ⁶-benzo[1,2,4]thiadiazine-7-sulfonic acid amide 
• 135-07-9 Methyclothiazid 
• 1027-12-9 5-Chlor-2.4-bis-methylsulfamoyl-anilin 
• 121-30-2 chloraminophenamide 
• 89813-56-9 6-chloro-3,4-dihydro-3-oxo-2H-1,2,4-benzothiadiazine-7-sulfonamide,1,1-dioxide 

Downstream Products

• 135-07-9 Methyclothiazid 
• 94204-72-5 6-chloro-2-methyl-3-(6-methyl-cyclohex-3-enyl)-1,1-dioxo-1,2,3,4-tetrahydro-1λ⁶-benzo[1,2,4]thiadiazine-7-sulfonic acid amide 
• 42583-55-1 6-Chlor-3.4-dihydro-3-methoxycarbonyl-2-methyl-7-sulfamoyl-2H-1.2.4-benzothiadiazin-1.1-dioxid 

Relevant articles and documents

Semiaqueous potentiometric determinations of apparent pKa1 values for benzothiadiazines and detection of decomposition during solubility variation with pH studies

-

SUBSTITUTED 4-PHENOXY OR 4-PHENYLTHIO PROLINES

Compounds of the formula STR1 are disclosed. They possess angiotensin converting enzyme inhibition activity and diuretic activity and are therefore useful as antihypertensive agents.